1824663-83-3
1824663-83-3
Chemical Structure
Sirtratumab vedotin
Synonym(s): AGS15E; ASG-15ME; 1vcMMAE
- CAS No.: 1824663-83-3
- Formula:N/A
- Molecular Weight:N/A
IUPAC Name: 4-(chloromethyl)-6-methoxypyrimidine
SMILES: [Sirtratumab vedotin]
Biological Activity: Sirtratumab vedotin (ASG15-ME) is an ADC composed of a SLITRK6-specific human gamma 2 antibody (Igγ2) conjugated to a small molecule microtubule disrupting agent, monomethyl auristatin E (MMAE) via a protease-cleavable linker[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Sirtratumab vedotin | 97.38% | Sirtratumab vedotin (ASG15-ME) is an ADC composed of a SLITRK6-specific human gamma 2 antibody (Igγ2) conjugated to a small molecule microtubule disrupting agent, monomethyl auristatin E (MMAE) via a protease-cleavable linker. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
